In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: The Vita Coco Company’s current price exceeds the PERT-weighted fair value by 9.6%, indicating potential overvaluation amid mixed valuation signals. Despite excellent financial health, high Monte Carlo downside risk (66.7%) and volatility (76.42%) highlight significant investment uncertainty. Analyst targets and DCF midpoint suggest upside potential, contrasting with lower P/E and EV/EBITDA benchmarks.